10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine

C136H109N11O3 — CID 167667494

IUPAC10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine
SMILESc1ccc(-c2cc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)cc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)nc(-c3ccccc3)n2)cc1.c1cncc(-c2nc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)nc(-c3cccnc3)n2)c1
InChIInChI=1S/C47H38N2O.C46H37N3O.C43H34N6O/c1-4-14-35(15-5-1)41-32-37(33-42(48-41)36-16-6-2-7-17-36)34-22-24-38(25-23-34)47(30-12-3-13-31-47)39-26-28-40(29-27-39)49-43-18-8-10-20-45(43)50-46-21-11-9-19-44(46)49;1-4-14-33(15-5-1)39-32-40(48-45(47-39)35-16-6-2-7-17-35)34-22-24-36(25-23-34)46(30-12-3-13-31-46)37-26-28-38(29-27-37)49-41-18-8-10-20-43(41)50-44-21-11-9-19-42(44)49;1-6-24-43(25-7-1,34-20-22-35(23-21-34)49-36-12-2-4-14-38(36)50-39-15-5-3-13-37(39)49)33-18-16-30(17-19-33)40-46-41(31-10-8-26-44-28-31)48-42(47-40)32-11-9-27-45-29-32/h1-2,4-11,14-29,32-33H,3,12-13,30-31H2;1-2,4-11,14-29,32H,3,12-13,30-31H2;2-5,8-23,26-29H,1,6-7,24-25H2
InChIKeySVVICIDFULEQMP-UHFFFAOYSA-N
MW1945.44 g/mol
LogP35.70
Rot. Bonds18

About 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine

10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine (PubChem CID 167667494) has the molecular formula C136H109N11O3 and a molecular weight of 1945.44 g/mol. Its IUPAC name is 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine.

Molecular Properties

Compound Name10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine
PubChem CID167667494
Molecular FormulaC136H109N11O3
Molecular Weight1945.44 g/mol
Exact Mass1943.87
IUPAC Name10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine
SMILESc1ccc(-c2cc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)cc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)nc(-c3ccccc3)n2)cc1.c1cncc(-c2nc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)nc(-c3cccnc3)n2)c1
InChIInChI=1S/C47H38N2O.C46H37N3O.C43H34N6O/c1-4-14-35(15-5-1)41-32-37(33-42(48-41)36-16-6-2-7-17-36)34-22-24-38(25-23-34)47(30-12-3-13-31-47)39-26-28-40(29-27-39)49-43-18-8-10-20-45(43)50-46-21-11-9-19-44(46)49;1-4-14-33(15-5-1)39-32-40(48-45(47-39)35-16-6-2-7-17-35)34-22-24-36(25-23-34)46(30-12-3-13-31-46)37-26-28-38(29-27-37)49-41-18-8-10-20-43(41)50-44-21-11-9-19-42(44)49;1-6-24-43(25-7-1,34-20-22-35(23-21-34)49-36-12-2-4-14-38(36)50-39-15-5-3-13-37(39)49)33-18-16-30(17-19-33)40-46-41(31-10-8-26-44-28-31)48-42(47-40)32-11-9-27-45-29-32/h1-2,4-11,14-29,32-33H,3,12-13,30-31H2;1-2,4-11,14-29,32H,3,12-13,30-31H2;2-5,8-23,26-29H,1,6-7,24-25H2
InChIKeySVVICIDFULEQMP-UHFFFAOYSA-N
XLogP35.70
TPSA140.53 Ų
H-Bond Donors
H-Bond Acceptors14
Rotatable Bonds18
Heavy Atoms150
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001945.44
LogP ≤ 535.70
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1014

Analyze 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine?
The IUPAC name of 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine (CID 167667494) is 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine.
What is the SMILES notation for 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine?
The canonical SMILES for 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine is c1ccc(-c2cc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)cc(-c3ccccc3)n2)cc1.c1ccc(-c2cc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)nc(-c3ccccc3)n2)cc1.c1cncc(-c2nc(-c3ccc(C4(c5ccc(N6c7ccccc7Oc7ccccc76)cc5)CCCCC4)cc3)nc(-c3cccnc3)n2)c1.
What is the InChIKey of 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine?
The InChIKey is SVVICIDFULEQMP-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H38N2O.C46H37N3O.C43H34N6O/c1-4-14-35(15-5-1)41-32-37(33-42(48-41)36-16-6-2-7-17-36)34-22-24-38(25-23-34)47(30-12-3-13-31-47)39-26-28-40(29-27-39)49-43-18-8-10-20-45(43)50-46-21-11-9-19-44(46)49;1-4-14-33(15-5-1)39-32-40(48-45(47-39)35-16-6-2-7-17-35)34-22-24-36(25-23-34)46(30-12-3-13-31-46)37-26-28-38(29-27-37)49-41-18-8-10-20-43(41)50-44-21-11-9-19-42(44)49;1-6-24-43(25-7-1,34-20-22-35(23-21-34)49-36-12-2-4-14-38(36)50-39-15-5-3-13-37(39)49)33-18-16-30(17-19-33)40-46-41(31-10-8-26-44-28-31)48-42(47-40)32-11-9-27-45-29-32/h1-2,4-11,14-29,32-33H,3,12-13,30-31H2;1-2,4-11,14-29,32H,3,12-13,30-31H2;2-5,8-23,26-29H,1,6-7,24-25H2.
What are the key properties of 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine?
10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine has a molecular weight of 1945.44 g/mol, XLogP of 35.70, 18 rotatable bonds, 0 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 10-[4-[1-[4-(2,6-diphenyl-4-pyridinyl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(2,6-diphenylpyrimidin-4-yl)phenyl]cyclohexyl]phenyl]phenoxazine;10-[4-[1-[4-(4,6-dipyridin-3-yl-1,3,5-triazin-2-yl)phenyl]cyclohexyl]phenyl]phenoxazine is sourced from PubChem (CID 167667494), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).